均瑶健康: 湖北均瑶大健康饮品股份有限公司关于2025年半年度募集资金存放与实际使用情况的专项报告

Key Points - The company raised a total of RMB 940.1 million through the issuance of 70 million shares at a price of RMB 13.43 per share, with a net amount of RMB 883.56 million after deducting issuance costs [1][2] - As of June 30, 2025, the remaining balance of raised funds is RMB 30.7 million, after accounting for previous investments and interest income [1][2] - The company has established special accounts for the management of raised funds, ensuring compliance with relevant regulations and protecting investor rights [2][3] - No idle raised funds were used to supplement working capital during the reporting period, and no funds were used for cash management [4][5] - The company has decided to extend the completion deadline for certain investment projects due to changes in market conditions and operational strategies [7][8] - The company plans to redirect unused funds from the brand upgrade project to support the bankruptcy restructuring of a subsidiary, which is expected to stabilize operations and enhance cost advantages [7][8] - The project for the new production facility in Yichang has reached its intended operational status, while the project in Zhejiang has been adjusted due to market demand uncertainties [12][14]